Scarica l'app Stockscreener
0.8977
0.26%
-0.0023
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Northern Trust Corp Buys 14,492 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
BNP Paribas Financial Markets Buys 68,234 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes By Investing.com - Investing.com Nigeria
Sutro Biopharma’s SWOT analysis: stock shifts focus amid pipeline changes - Investing.com
Sutro Biopharma unveils best-in-class anti-tissue factor ADC - BioWorld MedTech
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of “Hold” by Brokerages - Defense World
Sutro Biopharma (NASDAQ:STRO) Price Target Cut to $0.80 by Analysts at Bank of America - Defense World
Sutro Biopharma (STRO): Analyst Lowers Price Target by 20% | STR - GuruFocus
Bank of America Adjusts Sutro Biopharma (STRO) Price Target | ST - GuruFocus
Dimensional Fund Advisors LP Buys 156,139 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma Reports Q1 2025 Earnings and Restructuring - TipRanks
Transcript : Sutro Biopharma, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 04 - marketscreener.com
Sutro Biopharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Barclays PLC - Defense World
Sutro Biopharma Inc Reports Q1 2025 Revenue of $17.4M, Exceeding Estimates; EPS at -$0.91, Missing Projections - GuruFocus
Sutro Biopharma First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Sutro Biopharma, Inc. (STRO) Reports Q1 Loss, Tops Revenue Estimates - NewsBreak: Local News & Alerts
Sutro Biopharma earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - The Manila Times
Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights | STRO Stock News - GuruFocus
Sutro Biopharma, Inc. Advances ADC Pipeline Focus with Promising Preclinical Results and Strategic Reprioritization - Nasdaq
Financial Metrics Check: Sutro Biopharma Inc (STRO)’s Ratios for Trailing Twelve Months - DWinneX
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Invesco Ltd. - Defense World
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Sutro Biopharma (NASDAQ:STRO) Earns Neutral Rating from HC Wainwright - The AM Reporter
Sutro Biopharma to Participate in Upcoming Investor Conferences - The Manila Times
Leading ADC Developer Sutro Biopharma to Present at Citizens and BofA Healthcare Conferences in May - Stock Titan
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty - Benzinga
Sutro Biopharma (NASDAQ:STRO) Earns “Neutral” Rating from HC Wainwright - Defense World
Taking the lead: Sutro Biopharma Inc (STRO) - Sete News
Brokerages Set Sutro Biopharma, Inc. (NASDAQ:STRO) Price Target at $6.63 - The AM Reporter
Sutro Biopharma Inc [STRO] Investment Appeal on the Rise - knoxdaily.com
Demystifying Sutro Biopharma: Insights From 4 Analyst Reviews - Nasdaq
A stock that deserves closer examination: Sutro Biopharma Inc (STRO) - uspostnews.com
Sutro Biopharma to Highlight its Next-Generation Exatecan and Du - GuruFocus
Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025 - manilatimes.net
Sutro Biopharma Announces Poster Presentations on STRO-004 and XpressCF+® Platform at 2025 AACR Annual Meeting - Nasdaq
Revolutionary Dual-Payload Cancer Drug Shows Promise: Sutro's Next-Gen ADC Technology Impresses at AACR 2025 - Stock Titan
Sutro Biopharma Inc (STRO) Stock: A Year of Stock Market Ups and Downs - investchronicle.com
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Analysts - Defense World
Russell Investments Group Ltd. Has $183,000 Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
New fund will pressure flailing biotechs, as investor frustration boils over - Endpoints News
LPL Financial LLC Has $667,000 Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma Inc (STRO) gets rating Downgrade from H.C. Wainwright - knoxdaily.com
Anchoring Your Portfolio: Is STRO Stock a Safe Harbor? - investchronicle.com
Take off with Sutro Biopharma Inc (STRO): Get ready for trading - Sete News
Sutro Biopharma Inc (NASDAQ: STRO) – Analysts’ Revisions Point To Positive Sentiment - Stocksregister
Biopharma restructurings reflect strategy of short-term pain for long-term gains - BioWorld MedTech
Benign Growth For Sutro Biopharma, Inc. (NASDAQ:STRO) Underpins Stock's 36% Plummet - simplywall.st
Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges By Investing.com - Investing.com South Africa
Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges - Investing.com Canada
1.89%
3.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):